Ipca Laboratories Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

What the job involves

A Pharmacovigilance Analyst collects, processes, and evaluates adverse event reports for drugs and other healthcare products to ensure patient safety and regulatory compliance. Day to day, they triage cases, perform data entry into safety databases, conduct follow-ups for missing information, and assist in signal detection and periodic safety reports. In a company like Ipca Laboratories, they work closely with medical reviewers and regulatory teams to meet global pharmacovigilance requirements.

Role and Technical Knowledge

1. 1

   What is the difference between an adverse event (AE) and an adverse drug reaction (ADR)?

   Explain that an AE is any untoward medical occurrence after drug use, which may not be causally related, while an ADR is an AE with a reasonable causal relationship to the drug.

2. 2

   What are the key elements of a valid ICSR according to ICH E2B?

   Cover the four minimum criteria: an identifiable patient, an identifiable reporter, a suspect product, and an adverse event. Mention that missing information triggers follow-up.

3. 3

   How do you code an adverse event using MedDRA, and why is it important?

   Describe selecting the most specific Lowest Level Term (LLT) and its corresponding Preferred Term (PT) to standardize reporting and enable accurate signal detection.

4. 4

   What is the difference between a serious and non-serious adverse event?

   List the seriousness criteria: death, life-threatening, hospitalization or prolongation, disability, congenital anomaly, or medically important event. Emphasize that seriousness is not the same as severity.

Practical Scenarios and Case Processing

1. 5

   You receive a report of a patient who developed a rash after taking a medication. How would you process it?

   Walk through triage, data entry into the safety database, coding, assessing seriousness and expectedness, and determining if it is a valid ICSR. Mention follow-up for missing information.

2. 6

   What would you do if you received an adverse event report with missing patient age and reporter details?

   Explain that you would attempt follow-up to obtain the missing information, document the attempts, and if the case remains invalid, it may not be reportable but should still be recorded.

3. 7

   How would you handle a case where the adverse event is not listed in the product label?

   State that you would flag it as unexpected, assess causality, and ensure it is reported to regulatory authorities within the required timeline. Mention that it may contribute to a signal.

4. 8

   Describe how you would manage a high volume of cases with tight deadlines.

   Highlight prioritization based on seriousness and regulatory timelines, use of checklists, attention to detail, and communication with team members to avoid delays.

Regulatory and Compliance

1. 9

   What are the expedited reporting timelines for serious adverse events in India?

   Mention that serious unexpected adverse events must be reported to CDSCO within 15 calendar days, and fatal or life-threatening cases within 7 days, with a follow-up report within 8 additional days.

2. 10

   What is the role of the CDSCO in pharmacovigilance?

   Explain that CDSCO is the national regulatory authority that oversees drug safety, approves drugs, and monitors adverse events through the PvPI program.

3. 11

   What is the significance of 21 CFR Part 11 in pharmacovigilance?

   Describe it as a US FDA regulation that ensures electronic records and signatures are trustworthy, reliable, and equivalent to paper records, which is critical for safety databases.

4. 12

   How does the PvPI contribute to pharmacovigilance in India?

   Explain that the Pharmacovigilance Programme of India collects and analyzes ADR reports from healthcare professionals and consumers to ensure drug safety and promote rational use.

Behavioural and HR Questions

1. 13

   Why do you want to work in pharmacovigilance?

   Show passion for patient safety and explain how your education and skills align with the role. Mention a desire to contribute to drug safety monitoring.

2. 14

   Tell me about a time you had to pay close attention to detail.

   Use the STAR method to describe a situation where you caught an error or ensured accuracy, emphasizing the impact of your diligence.

3. 15

   How do you handle working under pressure or with strict deadlines?

   Provide an example of staying calm, prioritizing tasks, and communicating effectively to meet deadlines without compromising quality.

4. 16

   Where do you see yourself in five years in this field?

   Express a desire to grow into a senior PV role, gain expertise in signal detection or risk management, and contribute to team leadership.